Hide metadata

dc.date.accessioned2020-06-03T19:00:59Z
dc.date.available2020-10-31T23:46:18Z
dc.date.created2019-11-25T17:13:26Z
dc.date.issued2019
dc.identifier.citationStrand, Maren Ramaekers, Johannes Geradus Gjerde, Hallvard Mørland, Jørg Gustav Vindenes, Vigdis . Pharmacokinetics of single doses of methadone and suprenorphine in blood and oral fluid in healthy volunteers and correlation with effects on psychomotor and cognitive functions. Journal of Clinical Psychopharmacology. 2019, 39(5), 489-493
dc.identifier.urihttp://hdl.handle.net/10852/76614
dc.description.abstractPurpose We aimed to study the pharmacokinetics of methadone and buprenorphine in blood and oral fluid after single-dose administration and investigate correlations between concentrations in blood and neurocognitive functions. Methods A 5-way, double-blind, randomized, placebo-controlled, double-dummy, crossover study was performed to study the pharmacokinetics and neurocognitive effects of methadone (5 and 10 mg per oral) and buprenorphine (0.2 and 0.4 mg sublingual) in 22 healthy volunteers. Blood and oral fluid were collected throughout the test days, and drug concentrations in both matrices were analyzed using ultrahigh-performance liquid chromatography–tandem mass spectrometry. On-road driving testing, neurocognitive computerized tests, and subjective questionnaires were performed. Results Large individual variations in concentrations of methadone and buprenorphine in blood and oral fluid, and accordingly oral fluid/blood drug concentration ratios, were observed. The mean ratio 6.5 hours after drug administration was 2.0 (range, 0.49–7.39) for methadone after both doses. Buprenorphine was not detected above the limit of quantification in blood after 6.5 hours. No significant correlation between methadone concentration in blood and effect was found. Significant correlations were found between buprenorphine concentration in blood and standard deviation of lateral position in the driving test and some measures of reaction time, divided attention, balance, alertness, contentedness. and sleepiness. Conclusions Concentrations of methadone and buprenorphine in blood and oral fluid showed large interindividual variations. No concentration-effect correlations were found for methadone, whereas low to moderate correlations were observed between buprenorphine concentration and driving, psychomotor function, and subjective rating of sleep and alertness.
dc.languageEN
dc.publisherLippincott Williams & Wilkins
dc.titlePharmacokinetics of single doses of methadone and suprenorphine in blood and oral fluid in healthy volunteers and correlation with effects on psychomotor and cognitive functions
dc.typeJournal article
dc.creator.authorStrand, Maren
dc.creator.authorRamaekers, Johannes Geradus
dc.creator.authorGjerde, Hallvard
dc.creator.authorMørland, Jørg Gustav
dc.creator.authorVindenes, Vigdis
cristin.unitcode185,53,18,18
cristin.unitnameAvdeling for rettsmedisinske fag
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.fulltextpostprint
cristin.qualitycode1
dc.identifier.cristin1752081
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal of Clinical Psychopharmacology&rft.volume=39&rft.spage=489&rft.date=2019
dc.identifier.jtitleJournal of Clinical Psychopharmacology
dc.identifier.volume39
dc.identifier.issue5
dc.identifier.startpage489
dc.identifier.endpage493
dc.identifier.doihttps://doi.org/10.1097/JCP.0000000000001077
dc.identifier.urnURN:NBN:no-79724
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn0271-0749
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/76614/2/Strand_Vindenes_ARF_Cristin-post%2B1752081.pdf
dc.type.versionAcceptedVersion


Files in this item

Appears in the following Collection

Hide metadata